Stocks and Investing
Stocks and Investing
Wed, November 8, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sean Kim Downgraded (ARQT) to Hold on, Nov 8th, 2023
Sean Kim of JonesTrading, Downgraded "Arcutis Biotherapeutics, Inc." (ARQT) to Hold on, Nov 8th, 2023.
Sean has made no other calls on ARQT in the last 4 months.
There are 5 other peers that have a rating on ARQT. Out of the 5 peers that are also analyzing ARQT, 2 agree with Sean's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Uy Ear of "Mizuho" Downgraded from Strong Buy to Hold and Decreased Target to $4 on, Friday, October 27th, 2023
- Jonathan Block of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $6 on, Friday, October 13th, 2023
These are the ratings of the 3 analyists that currently disagree with Sean
- Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $8 on, Monday, November 6th, 2023
- Louise Chen of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $50 on, Tuesday, August 22nd, 2023
- Ken Cacciatore of "TD Cowen" Maintained at Buy with Decreased Target to $50 on, Wednesday, August 9th, 2023
Contributing Sources